Investigation of Low-intensity Focused Ultrasound for Human Pain Management
- Conditions
- Chronic Pain
- Interventions
- Device: Low Intensity Focused Ultrasound
- Registration Number
- NCT05145426
- Brief Summary
This project examines the effects of noninvasive brain stimulation on pain. The investigators believe this study will help to better understand possible treatments for chronic pain patients. Participants undergo structural imaging, a functional Magnetic Resonance Image (fMRI) and computed tomography (CT). These images are used to align the low-intensity focused ultrasound (LIFU) device which uses sound waves to temporarily change brain activity. Pain testing is done using a small device that will increase/decrease the temperature of the skin. Brain signals are collected using electroencephalography (EEG). Heart rate, blood pressure, and skin moisture will be monitored as well.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 80
- Understand and speak English
-
MRI/CT/EEG contraindications.
- Claustrophobia
- Contraindications to MRI: including pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants.
- Contraindications to CT: pregnancy
- Active medical disorder or treatment with potential CNS effects
- History of neurologic disorder
- History of head injury resulting in loss of consciousness for >10 minutes.
- History of alcohol or drug dependence
- Failure to provide Social Security Number or Tax ID number. This is required for tax purposes or payment cannot be processed.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Pain Trials Low Intensity Focused Ultrasound Multi visit - LIFU/Sham application, with quantitative sensory testing (using peltier device).
- Primary Outcome Measures
Name Time Method Perceived sensation score Assessed per participant, over the course of participation - an average of 3 weeks. Changed perceived sensation score on a 1-10 scale in response to painful stimuli.
- Secondary Outcome Measures
Name Time Method Windup Pain Assessed per participant, over the course of participation - an average of 3 weeks Changed windup pain score on a 1-10 scale.
CHEP Amplitude Assessed per participant, over the course of participation - an average of 3 weeks Attenuated N1/P1 CHEP amplitude recorded with EEG
Trial Locations
- Locations (1)
Fralin Biomedical Research Institute
🇺🇸Roanoke, Virginia, United States